Susan Gannon, MD
Plastic and Reconstructive Surgery · Albany, NYNPI 1063471209
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,202 of the $5,848 with a category attached, or 71.8%. 12 manufacturers reported payments, led by AbbVie at 52.4% of the total. Reporting peaked in 2024 at $2,399 and has fallen 77.1% since, to $549 in 2025.
Across 115 payments — averaging $50.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Sientra, Inc.$873
- Galderma Laboratories, L.p.$801
- Biom'up France SAS$310
- Motiva USA, LLC$288
- Merz North America, Inc.$233
- plus $277 from 6 others
What the payments were for
- Travel & lodging$1,61228%
- Food & beverage$4,20272%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 52 | $3,066 |
| Sientra, Inc. | 16 | $873 |
| Galderma Laboratories, L.p. | 23 | $801 |
| Biom'up France SAS | 2 | $310 |
| Motiva USA, LLC | 7 | $288 |
| Merz North America, Inc. | 6 | $233 |
| Johnson & Johnson | 3 | $134 |
| KCI USA, Inc. | 1 | $41 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
| Mentor Worldwide LLC | 1 | $30 |
| Acera Surgical, Inc. | 1 | $23 |
| TELA Bio, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,848 in reported general payments places this provider in the 75th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 20 | $160 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Albany
- Thomas DavenportGarden City$2.8M
- Howard LangsteinRochester$350K
- James BradleyNew Hyde Park$306K
- David FuntWoodmere$295K
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Tara HustonStony Brook$95K
- Theodore DiktabanNew York$83K
- Jeffrey RidhaSaratoga Springs$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.